Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.50 (3.70%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.86m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Trading update & extended CLNs and warrant terms

16 Oct 2025 07:00

RNS Number : 5717D
Insig AI Plc
16 October 2025
 

16 October 2025

Insig AI plc

("Insig AI" or the "Company")

 

Trading and strategic operations update, and

Extended terms of Convertible Loan Notes and warrants

 

Insig AI plc (AIM:INSG), a provider of AI-led analytics and machine learning solutions is today holding its annual general meeting ("AGM") and issues the following update, together with an extension of the terms of certain convertible loan notes and warrants.

 

Trading and strategic operations update

 

Further to the Company's trading update on 7 October, revenue for the six months to 30 September 2025 is now expected to be marginally higher at just under £440k, which is more than 164% ahead of the equivalent period last year. Very recent new sales leads provide encouragement for the outturn for the full year.

 

The Company has also recently raised gross proceeds of £1.0m for general working capital purposes including bolstering Insig AI's sales activities and the continuing evaluation of strategic options, including potential structures around investing in digital assets and related enterprises. The Directors believe that enabling investors to gain access to digital asset exposure in a London listed entity harnessing the Company's machine learning data insights managed by an investment team with a proven track record, will resonate with investors and can become a highly attractive and scalable offering. The Company will provide further updates when appropriate.

 

Externed terms of convertible loan notes and warrants

 

The Company is also pleased to announce the redemption dates of the Company's existing convertible loan notes ("CLN") of £1,000,000 and £500,000 issued to Richard Bernstein and David Kyte respectively, have been extended by 15 months to 31 December 2026. All other terms of the CLNs remain unchanged.

 

Additionally, the expiry date of the 1,666,667 and 1,388,889 warrants to Richard Bernstein and David Kyte respectively have been extended by 15 months to 31 March 2027. All other terms of the warrants remain unchanged.

 

The revised terms of the CLN and warrants to Richard Bernstein, due to him being a director of the Company, are deemed to be related party transactions pursuant to AIM Rule 13. The directors of the Company (excluding Richard Bernstein), having consulted with Zeus Capital Limited, the Company's nominated adviser, consider that each of the revised terms of the CLN and the warrants to Richard Bernstein are fair and reasonable insofar as the Company's shareholders are concerned.

 

Richard Bernstein, CEO, commented: "We're pleased to have attracted fresh investment which enables us to further develop the business alongside new opportunities including potentially focusing on digital assets.

 

Furthermore, I'm pleased that the convertible loan notes and warrants have been extended, which strengthens our balance sheet during this important period for the Company."

 

For further information, please visit www.insg.ai or contact:

 

Insig AI plc richard.bernstein@insg.ai

Richard Bernstein (CEO)

Zeus (Nominated Adviser & Joint Broker)

David Foreman / James Hornigold +44 (0)20 3829 5000

 

CMC Markets (Joint Broker) +44 (0)20 3003 8632

Douglas Crippen

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMABTTMTMBTTA
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.